Sorrento Therapeutics Inc...
0.00
-0.00 (-100.00%)
At close: Jan 15, 2025, 3:23 PM
0.00
-40.00%
Pre-market Jan 02, 2025, 09:30 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income -577.76M -429.14M -314.41M -363.01M -203.54M 9.06M -60.92M -50.07M -34.66M -21.91M -4.85M -3.24M -1.81M -942.27K -188.90K -270.62K -439.29K 308.03K -763 -763
Depreciation & Amortization 13.24M 12.46M 11.01M 10.99M 9.05M 7.08M 2.88M 2.37M 3.18M 1.29M 293.30K 159.22K 23.41K 2.75K n/a n/a n/a n/a n/a n/a
Stock-Based Compensation 74.85M 90.19M 31.42M 12.65M n/a 4.95M 4.74M 6.97M 3.94M 1.79M 863.13K 298.03K 250.95K 54.52K n/a n/a n/a n/a n/a n/a
Other Working Capital 74.87M -4.57M -1.68M -2.97M 4.04M -18.68M 22.30M 9.88M 275.00K -557.43K -66.90K -7.08K 121.82K 5.41K -14.06K n/a n/a -298.49K n/a 763.00
Other Non-Cash Items 128.09M 83.39M 110.77M 159.50M 98.99M -48.96M -36.85M -49.48M 693.00K 1.90M n/a -3.24M n/a n/a n/a 71.00K n/a n/a n/a n/a
Deferred Income Tax -1.84M -35.93M -2.13M -373.00K -6.12M -35.68M 982.00K 33.34M -1.70M n/a n/a 3.24M n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 69.55M -2.79M 3.80M 7.25M 6.00M -17.60M 25.54M 14.80M -222.00K 437.97K -108.60K 35.86K -12.80K 150.02K -15.02K -468.50K 439.29K -298.49K 763.00 763.00
Operating Cash Flow -293.86M -281.82M -159.54M -173.00M -111.77M -99.18M -70.89M -42.07M -28.76M -16.49M -3.80M -2.74M -1.55M -734.96K -203.92K -668.12K n/a 9.54K n/a n/a
Capital Expenditures -13.66M -8.87M -37.58M -11.44M -21.20M -10.97M -6.86M -3.71M -591.00K -931.30K -547.88K -1.05M -46.03K -45.52K n/a n/a n/a n/a n/a n/a
Acquisitions -14.86M -36.05M -2.34M -9.69M n/a -557.00K -9.84M 27.76M n/a 427.82K n/a n/a n/a 104.86K n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a -35.30M -2.34M -9.69M n/a -5.00M -750.00K -11.50M -10.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a 124.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a -17.04M -10.00M n/a n/a n/a n/a -83.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -28.52M 79.85M -39.92M -38.17M -21.20M -16.53M -17.45M 12.55M -10.59M -503.48K -547.88K -1.05M -46.03K 59.34K n/a n/a n/a n/a n/a n/a
Debt Repayment -92.24M -35.91M -186.98M 22.34M 242.18M -3.24M 38.87M -3.10M 7.50M 6.85M n/a n/a n/a n/a n/a n/a n/a -9.54K n/a n/a
Common Stock Repurchased n/a n/a -55.00M n/a n/a n/a -15.64M n/a n/a n/a n/a -43 n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.62M 15.42M 98.35M 8.85M 211.00K -1.01M 524.00K -252.00K 304.00K -982.49K 36.12K 13.13K n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow 311.72M 181.33M 174.24M 78.89M 326.00M 53.67M 131.74M -3.35M 79.59M 43.57M 5.97M 1.98M 3.44M 4.11M 562.50K 690.00K n/a -9.54K n/a n/a
Net Cash Flow -13.03M -19.80M -24.30M -132.56M 147.90M -61.97M 43.36M -32.86M 40.23M 26.58M 1.62M -1.81M 1.85M 4.11M 358.58K 21.88K n/a n/a n/a n/a
Free Cash Flow -307.51M -290.69M -197.12M -184.44M -132.96M -110.15M -77.75M -45.78M -29.36M -17.42M -4.35M -3.80M -1.59M -780.49K -203.92K -668.12K n/a 9.54K n/a n/a